Balance Sheet for Momenta Pharmaceuticals Inc. (MNTA)

$ 33.80   -0.16 (-0.47%) Volume: 1.81m 4:00 PM EST Feb 21, 2020
After Hours:  $ 33.80 0.00 (0.00%) Volume: 8.51k 4:26 PM EST Feb 21, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 248,334 73,651 150,738 61,461 61,349
Restrictable Cash - 2,412 21,761 20,660 20,719
Marketable Securities 174,076 269,017 202,413 288,583 130,180
Accounts Receivable 11,371 15,048 70,242 21,185 7,427
Loans Receivable - - - - -
Other Receivables - - - 1,800 2,909
Receivables 11,371 15,048 70,242 21,185 10,336
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 6,318 6,798 4,607 3,479 3,465
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 441,423 366,926 428,000 374,708 205,330
Land and Improvements - - - - -
Buildings and Improvement 23,932 25,356 13,333 12,735 12,735
Machinery, Furniture and Equipment 33,486 67,968 64,082 58,136 54,068
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 57,418 93,324 77,415 70,871 66,803
Gross Fixed Assets 57,418 93,324 77,415 70,871 66,803
Accumulated Depreciation (36,474) (63,408) (56,568) (48,975) (41,381)
Net Fixed Assets 20,944 29,916 20,847 21,896 25,422
Intangibles 2,883 4,036 5,189 3,528 4,589
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 39,312 21,331 23,701 20,908 20,875
Total Non-Current Assets 90,140 92,505 49,737 46,332 50,886
Total Assets 531,563 459,431 477,737 421,040 256,216
Liabilities [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 9,352 11,456 3,632 4,053 7,433
Short Term Debt 128 - - - -
Notes Payable - - - - -
Accrued Expenses 9,189 11,785 17,452 16,651 3,436
Accrued Liabilities 9,189 11,785 17,452 16,651 3,436
Deferred Revenues 23,637 12,124 40,167 9,770 5,490
Current Deferred Income Taxes - - - - -
Other Current Liabilities 9,205 9,122 9,425 8,308 7,430
Total Current Liabilities 51,511 44,487 70,676 38,782 23,789
Long Term Debt 916 - - - -
Deferred Income Tax 10,251 37,249 31,360 12,213 25,508
Other Non-Current Liabilities 18,128 40,790 35,153 12,282 26,059
Minority Interest - - - - -
Capital Lease Obligations 916 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 19,044 40,790 35,153 12,282 26,059
Total Liabilities 70,555 85,277 105,829 51,064 49,848
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 461,008 374,154 371,908 369,976 206,368
Common Par 10 8 7 7 5
Additional Paid in Capital 1,208,025 939,654 848,304 824,385 575,438
Cumulative Translation Adjustments - - - - -
Retained Earnings (743,826) (562,254) (473,375) (452,372) (369,059)
Treasury Stock 3,114 3,114 3,114 2,048 -
Other Equity Adjustments (87) (140) 86 4 (16)
Total Capitalization 461,008 374,154 371,908 369,976 206,368
Total Equity 461,008 374,154 371,908 369,976 206,368
Total Liabilities & Shareholder's Equity 531,563 459,431 477,737 421,040 256,216
Cash Flow (186,693) (97,439) (30,720) (93,351) (109,460)
Working Capital 389,912 322,439 357,324 335,926 181,541
Free Cash Flow (164,609) (46,212) 2,279 (75,583) (73,528)
Invested Capital 461,008 374,154 371,908 369,976 206,368
Shares Outstanding - Common Class Only 98,464 76,355 71,076 69,077 54,486
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 98,464 76,355 71,076 69,077 54,486
Total Common Shares Outstanding 98,464 76,355 71,076 69,077 54,486
Treasury Shares 230 229 229 119 -
Basic Weighted Shares Outstanding 77,845 73,136 68,656 63,130 51,664
Diluted Weighted Shares Outstanding 77,845 73,136 68,656 63,130 51,664